Croixstone

Community
Engagement

We encourage success beyond our doorstep.
giving back

Croixstone drives transformations in our community, too.

Croixstone Consulting amplifies our impact in the community through deep involvement in a targeted portfolio of nonprofit organizations and professional associations.
We drive excellence in private company board governance.  We fuel social innovation.  We heighten awareness for a disease that has taken from us too soon a mom, a dad, and a beloved niece.

Private Directors Association

The Private Directors Association (PDA) is a 501(c)(6) organization with a sole focus on the unique governance needs of private companies.  Excellence in governance drives private company growth which in turn helps build strong communities and economies. 

Croixstone is actively involved in the Charlotte Chapter of the PDA and we serve as a Bronze Chapter Sponsor.
Learn More

Social Venture Partners

Social Venture Partners Charlotte (SVP) is a 501(c)(3) with a mission to invest in and strengthen innovative nonprofits who are tackling our community’s great challenges by leveraging a network of engaged philanthropists.
 
In addition to using a venture philanthropy model to “invest” in a select portfolio of nonprofits, SVP hosts SEED20, an annual program that discovers, spotlights, and supports innovative ideas to drive social good.
 
Croixstone is deeply involved in serving SVP’s mission and we are a Corporate Partner of this exceptionally unique nonprofit.
Learn More

Charlotte Pancreatic Cancer Alliance

Pancreatic cancer has the highest mortality rate of all major cancers and is currently the 3rd leading cause of cancer-related death in the USA. 

Three of Croixstone’s leaders lost family members to this underfunded and little understood disease.  Patti Weber, Mark Weber, and Grace Lynch launched Charlotte Pancreatic Cancer Alliance as a nonprofit community group to increase awareness and funding for the disease.

Join us in our efforts to save lives and create a future without pancreatic cancer.
Learn More